Key result
Mean platelet volume was an independent predictor for the development of long-term major adverse cardiovascular events in hypertensive patients (P=0.049).
Why the study?
Although high mean platelet volume is linked to target organ damage in hypertensive patients, its relationship with long-term major adverse cardiovascular events has not been thoroughly investigated.
Does mean platelet volume predict long-term major adverse cardiovascular events in patients with hypertension?
Cohort (n=1,507)
Does mean platelet volume predict long-term major adverse cardiovascular events in patients with hypertension?
p-value: p=0.049
Mean platelet volume is an independent predictor of long-term major adverse cardiovascular events in patients with hypertension.
No takes yet. Share an insight, caveat, or question.
Should not yet alter hypertension management; leaves open MPV's incremental prognostic value pending validation.
Püşüroğlu et al. (2021) conducted a cohort in Hypertension (n=1,507). Mean platelet volume (MPV) was evaluated on Major adverse cardiovascular events (myocardial infarction, stroke, and cardiovascular mortality) (p=0.049). Mean platelet volume was an independent predictor for the development of long-term major adverse cardiovascular events in hypertensive patients (P=0.049).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: